Evaluation of primary opioid receptor antibodies for use in western blotting

British Journal of Anaesthesia

Volumn 108, Issue 3, 2012, Pages 530-532

  Niwa, H ^a   Rowbotham, D J ^a   Lambert, D G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; OPIATE ANTAGONIST;

ANIMAL CELL; CHO CELL; CONTROLLED STUDY; HUMAN; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84857325047     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes015     Document Type: Letter

References (8)

1. Michel MC, Wieland T, Tsujimoto G. How reliable are G-proteincoupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 385-8
2. Bordeaux J, Welsh A, Agarwal S, et al. Antibody validation. Biotechniques 2010; 48: 197-209
3. Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, Kummer W. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 389-95
4. Jensen BC, Swigart PM, Simpson PC. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 409-12
5. Huang P, Liu-Chen LY. Detecting the mu opioid receptor in brain following SDS-PAGE with multiple approaches. Front Biosci (Elite Ed) 2009; 1: 220-7
6. Couchman JR. Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 2009; 57: 7-8
7. Grimsey NL, Goodfellow CE, Scotter EL, Dowie MJ, Glass M, Graham ES. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! J Neurosci Methods 2008; 171: 78-86
8. Saper CB. An open letter to our readers on the use of antibodies. J Comp Neurol 2005; 493: 477-8 (Pubitemid 41780622)